Circulating Levels of Urokinase-Type Plasminogen Activator (uPA) and its Soluble Receptor (suPAR) in Patients with Atopic Eczema/Dermatitis Syndrome

Author： Kasperska-Zajac Alicja   Rogala Barbara  

Publisher： Springer Publishing Company

ISSN： 0360-3997

Source： Inflammation, Vol.29, Iss.2-3, 2005-06, pp. : 90-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 3, 2015-03 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atopic Eczema/Dermatitis Syndrome and Malassezia

By  

International Archives of Allergy and Immunology, Vol. 127, Iss. 3, 2002-04 ,pp. : 161-169

Karger

Access to resources Recommend Favorite

Soluble urokinase‐type plasminogen activator receptor as a putative marker of male accessory gland inflammation

By  

ANDROLOGY, Vol. 3, Iss. 6, 2015-11 ,pp. : 1054-1061

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhanced Platelet Activation in Patients with Atopic Eczema/Dermatitis Syndrome

By Kasperska-Zaj¸c Alicja   Nowakowski Marek   Rogala Barbara  

Inflammation, Vol. 28, Iss. 5, 2004-10 ,pp. : 299-302

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Urokinase-Type Plasminogen Activator and Its Receptor in Neointima of Polyester Vascular Grafts

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-11 ,pp. : 23-28

Karger

Access to resources Recommend Favorite